HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer.

AuthorsClemens Kratochwil, Frederik L Giesel, Matthias Eder, Ali Afshar-Oromieh, Martina Benešová, Walter Mier, Klaus Kopka, Uwe Haberkorn
JournalEuropean journal of nuclear medicine and molecular imaging (Eur J Nucl Med Mol Imaging) Vol. 42 Issue 6 Pg. 987-8 (May 2015) ISSN: 1619-7089 [Electronic] Germany
PMID25573634 (Publication Type: Case Reports, Journal Article)
Chemical References
  • 177Lu-DKFZ-617
  • Antigens, Surface
  • Organometallic Compounds
  • Peptides
  • Radiopharmaceuticals
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II
Topics
  • Antigens, Surface (metabolism)
  • Glutamate Carboxypeptidase II (metabolism)
  • Humans
  • Male
  • Multimodal Imaging
  • Neoplasm Metastasis
  • Organometallic Compounds (pharmacokinetics, therapeutic use)
  • Peptides (pharmacokinetics, therapeutic use)
  • Positron-Emission Tomography
  • Prostatic Neoplasms (diagnostic imaging, radiotherapy)
  • Radiopharmaceuticals (therapeutic use)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: